<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01961206</url>
  </required_header>
  <id_info>
    <org_study_id>SRRSH-ESBL01</org_study_id>
    <nct_id>NCT01961206</nct_id>
  </id_info>
  <brief_title>Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and Prognosis</brief_title>
  <official_title>Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase (ESBL)Producing Escherichia Coli or Klebsiella Pneumoniae in China: Prevalence, Risk Factors and Prognosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jian-cang Zhou M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sir Run Run Shaw Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Escherichia coli is the leading cause of community-onset gram-negative bloodstream
      infections. There has been a dramatic increase in the prevalence of extended-spectrum
      b-lactamases producing E. coli and K.pneumoniae in the community, which was considered to be
      exclusively a nosocomial pathogen in recent years. As a result, the treatment options for
      community-onset infections due to ESBL-producing E. coli or K.pneumoniae are limited and the
      initial empirical therapy is often ineffective and associated with increased mortality.
      Although there were some reports of the risk factors of community-onset ESBL producing E.
      coli in Spain, Korea, and Canada, few empirical data were available about China. Therefore,
      the investigators aim was to investigate the epidemiology, risk factors, and the hospital
      outcomes for patients with community-onset bacteremia caused by ESBL producing E. coli or
      K.pneumoniae in China.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligibility criteria:

        1. Inclusion criteria:Blood cultures demonstrated E.coli or K.pneumoniae among
           nonhospitalized patients or within 48 h after hospitalization.

        2. Exclusion criteria:Patients with hospitalization in the past 1 month.

      Outcome measures:

        1. Risk factors for community-onset bacteremia due to ESBL producing E. coli or
           K.pneumoniae

        2. Microbial and clinical efficacy of commonly used antibiotics for community-onset
           bacteremia due to ESBL producing E. coli or K.pneumoniae
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Risk factors for community-onset bacteremia caused by ESBL producing E.coli or K.pneumoniae</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">960</enrollment>
  <condition>Community Acquired Infection</condition>
  <arm_group>
    <arm_group_label>Case Patients</arm_group_label>
    <description>Case Patients with Community-Onset Bacteremia Due toESBL producing E.coli or K.pneumoniae</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>bacteremia caused by ESBL producing E.coli or K.pneumoniae</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>bacteremia caused by ESBL producing E.coli or K.pneumoniae</intervention_name>
    <description>community-onset bacteremia caused by ESBL producing E.coli or K.pneumoniae</description>
    <arm_group_label>Case Patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      bacterial strains
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All adult patients visited any of the 28 particitant hospitals during the study period were
        screened. Patients with community-onset bacteremia caused by E.coli or K. pneumoniae and
        without a recent hospitalization in any hospital will be included
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  older than 18 years old

          -  community-onset bacteremia

        Exclusion Criteria:

          -  recent hospitalization within one month in any hospital
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yun-song YU, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sir Run Run Shaw Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sir Run Run Shaw Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310016</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Ruíz M, Peña C, Almela M, Almirante B, Grill F, Colomina J, Giménez M, Oliver A, Horcajada JP, Navarro G, Coloma A, Pascual A; Spanish Network for Research in Infectious Diseases (REIPI). Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis. 2010 Jan 1;50(1):40-8. doi: 10.1086/649537.</citation>
    <PMID>19995215</PMID>
  </results_reference>
  <results_reference>
    <citation>Apisarnthanarak A, Kiratisin P, Mundy LM. Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2008 Jul;29(7):671-4. doi: 10.1086/588082.</citation>
    <PMID>18624669</PMID>
  </results_reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2013</study_first_submitted>
  <study_first_submitted_qc>October 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 11, 2013</study_first_posted>
  <last_update_submitted>November 19, 2015</last_update_submitted>
  <last_update_submitted_qc>November 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Sir Run Run Shaw Hospital</investigator_affiliation>
    <investigator_full_name>Jian-cang Zhou M.D.</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Bacteremia</mesh_term>
    <mesh_term>Community-Acquired Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

